United States

Normalized AFFO (TTM)

Normalized AFFO/share (TTM)

Normalized AFFO/share Guidance

Normalized AFFO (Quarter)

Normalized AFFO/share (Quarter)

Price/Normalized AFFO

We operate as a self-administered, self-managed REIT that, through our subsidiaries, owns and invests in real estate serving the healthcare industry. Our primary business consists of acquiring, financing and owning real estate property to be leased to third party tenants in the healthcare sector. We primarily generate revenues by leasing properties to tenants and operators throughout the United States and Canada.

Sabra Health Care

If the REIT is managed by an internal (employees) or external (separate company) team

As a long-term debt issuer, SBRA is classified as speculative grade

Year: 2019

Years since IPO: 10/15,
Normalized AFFO Growth: 10/15,
Normalized AFFO/share Growth: 0/20,
Dividend Growth: 18/20,
Payout Ratio: 5/15,
Debt: 13/15
            

Year: 2020

Years since IPO: 10/15,
Normalized AFFO Growth: 15/15,
Normalized AFFO/share Growth: 0/20,
Dividend Growth: 0/20,
Payout Ratio: 15/15,
Debt: 13/15
            

Year: 2021

Years since IPO: 15/15,
Normalized AFFO Growth: 10/15,
Normalized AFFO/share Growth: 0/20,
Dividend Growth: 0/20,
Payout Ratio: 15/15,
Debt: 15/15
            

Year: 2022

Years since IPO: 15/15,
Normalized AFFO Growth: 5/15,
Normalized AFFO/share Growth: 0/20,
Dividend Growth: 3/20,
Payout Ratio: 15/15,
Debt: 12/15
            

Year: 2023

Years since IPO: 15/15,
Normalized AFFO Growth: 0/15,
Normalized AFFO/share Growth: 0/20,
Dividend Growth: 3/20,
Payout Ratio: 10/15,
Debt: 10/15
            

Year: 2024

Years since IPO: 15/15,
Normalized AFFO Growth: 5/15,
Normalized AFFO/share Growth: 5/20,
Dividend Growth: 3/20,
Payout Ratio: 10/15,
Debt: 10/15
            

Years since IPO

Analysis of the recent Normalized AFFO performance

Normalized AFFO Growth

Analysis of the recent Normalized AFFO per share performance

Normalized AFFO/share Growth

Analysis of the recent Dividend track record

Dividend Growth

Payout level to determine if the dividend is safe

Payout Ratio

Debt analysis that uses Debt/Assets and Debt/EBITDA to determine if leverage levels are under control

Debt

Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q1 2024 Earnings Conference Call May 9, 2024 1:00 PM ET Company Participants Lukas Hartwich - SVP, Finance Rick Matros - Chief Executive Officer, President & Chair of the Board Talya Nevo-Hacohen - Chief Investment Officer, Treasurer & Executive Vice President Michael Costa - Chief Financial Officer Conference Call Participants Austin Wurschmidt - KeyBanc Joshua Dennerlein - Bank of America Michael Griffin - Citigroup Vikram Malhotra - Mizuho Rich Anderson - Wedbush Michael Stroyeck - Green Street Operator Good day everyone. My name is Katherine and I will be your conference operator today.

Sabra Health Care REIT, Inc. (SBRA) Q1 2024 Earnings Call Transcript

Sabra Health Care REIT has outperformed the Vanguard Real Estate Index Fund ETF in 2024. I expect the robust performance to continue, with the company confirming its normalized FFO outlook of $1.36/share, up 4.6% Y/Y.

Sabra Healthcare REIT: An Attractive Value Proposition With Moderate Leverage

The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Compared to Estimates, Sabra (SBRA) Q1 Earnings: A Look at Key Metrics

Evaluate the expected performance of Sabra (SBRA) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Exploring Analyst Estimates for Sabra (SBRA) Q1 Earnings, Beyond Revenue and EPS

TUSTIN, Calif.--(BUSINESS WIRE)-- #1Q24--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2024 first quarter earnings release on May 8, 2024, after the close of trading. A conference call with a simultaneous webcast to discuss the 2024 first quarter results will be held on Thursday, May 9 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number i.

Sabra Health Care REIT, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call

The Investment Committee give you their top stocks to watch for the second half.

Final Trades: Steel Dynamics, Sabra Health Care, ASML Holding and Deere

TUSTIN, Calif.--(BUSINESS WIRE)-- #DeutscheBank--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Talya Nevo-Hacohen, the company's Chief Investment Officer, and Darrin Smith, the company's Executive Vice President of Investments, will attend the Deutsche Bank Inaugural Healthcare REIT Summit virtually on April 2, 2024. About Sabra Sabra Health Care REIT, Inc., a Maryland corporat.

Sabra Health Care REIT, Inc. to Attend the Deutsche Bank Inaugural Healthcare REIT Summit

Generating steady income from rentals and a historical resilience in the face of economic adversities make real investment trusts (REITs) a viable choice for growth investors and those hedging against inflation. While residential REITs may be the most familiar type of REITs, medical and healthcare REITs can also be one of the most profitable additions to your investment portfolio.

Healthcare havens: The medical REIT with a pulse on the future

The company offers medicines and vaccines in various therapeutic areas, including: Cardiovascular metabolic and women's health under the Premarin family and Eliquis brands Biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands Sterile injectable and anti-infective medicines and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands.

6 Bargain Dividend Stocks To Buy

Sabra Health Care REIT, Inc. (SBRA) Q4 2023 Earnings Call Transcript

IRVINE, Calif.--(BUSINESS WIRE)-- #4Q23--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2023 fourth quarter earnings release on February 27, 2024, after the close of trading. A conference call with a simultaneous webcast to discuss the 2023 fourth quarter results will be held on Wednesday, February 28 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-596-4144. For participants outside the U.S., the dial-in number is 646-968-2525. The confere.

Sabra Health Care REIT, Inc. Announces Fourth Quarter 2023 Earnings Release Date and Conference Call; Declares Common Dividend

TUSTIN, CALIF.--(BUSINESS WIRE)-- #1Q24--SABRA HEALTH CARE REIT, INC. (NASDAQ: SBRA) ANNOUNCED TODAY THAT IT WILL ISSUE ITS 2024 FIRST QUARTER EARNINGS RELEASE ON MAY 8, 2024, AFTER THE CLOSE OF TRADING. A CONFERENCE CALL WITH A SIMULTANEOUS WEBCAST TO DISCUSS THE 2024 FIRST QUARTER RESULTS WILL BE HELD ON THURSDAY, MAY 9 AT 10:00 A.M. PACIFIC TIME. THE DIAL-IN NUMBER FOR U.S. PARTICIPANTS IS 888-880-4448. FOR PARTICIPANTS OUTSIDE THE U.S., THE DIAL-IN NUMBER IS 646-960-0572. THE CONFERENCE ID NUMBER I.

SABRA HEALTH CARE REIT, INC. ANNOUNCES FIRST QUARTER 2024 EARNINGS RELEASE DATE AND CONFERENCE CALL

TUSTIN, CALIF.--(BUSINESS WIRE)-- #DEUTSCHEBANK--SABRA HEALTH CARE REIT, INC. (NASDAQ: SBRA) ANNOUNCED TODAY THAT RICK MATROS, THE COMPANY'S CHAIR AND CHIEF EXECUTIVE OFFICER, MICHAEL COSTA, THE COMPANY'S CHIEF FINANCIAL OFFICER, TALYA NEVO-HACOHEN, THE COMPANY'S CHIEF INVESTMENT OFFICER, AND DARRIN SMITH, THE COMPANY'S EXECUTIVE VICE PRESIDENT OF INVESTMENTS, WILL ATTEND THE DEUTSCHE BANK INAUGURAL HEALTHCARE REIT SUMMIT VIRTUALLY ON APRIL 2, 2024. ABOUT SABRA SABRA HEALTH CARE REIT, INC., A MARYLAND CORPORAT.

SABRA HEALTH CARE REIT, INC. TO ATTEND THE DEUTSCHE BANK INAUGURAL HEALTHCARE REIT SUMMIT

TUSTIN, CALIF.--(BUSINESS WIRE)-- #CITI--SABRA HEALTH CARE REIT, INC. (NASDAQ: SBRA) ANNOUNCED TODAY THAT RICK MATROS, THE COMPANY'S CHAIR AND CHIEF EXECUTIVE OFFICER, MICHAEL COSTA, THE COMPANY'S CHIEF FINANCIAL OFFICER, AND LUKAS HARTWICH, THE COMPANY'S SENIOR VICE PRESIDENT OF FINANCE, WILL ATTEND CITI'S 2024 GLOBAL PROPERTY CEO CONFERENCE ON MARCH 4-6, 2024, AT THE DIPLOMAT BEACH RESORT IN HOLLYWOOD, FLORIDA. ADDITIONALLY, TALYA NEVO-HACOHEN, THE COMPANY'S CHIEF INVESTMENT OFFICER, DARRIN SMITH, TH.

SABRA HEALTH CARE REIT, INC. TO ATTEND CITI'S 2024 GLOBAL PROPERTY CEO CONFERENCE AND THE 2024 NIC SPRING CONFERENCE

IRVINE, CALIF.--(BUSINESS WIRE)-- #4Q23--SABRA HEALTH CARE REIT, INC. (NASDAQ: SBRA) ANNOUNCED TODAY THAT IT WILL ISSUE ITS 2023 FOURTH QUARTER EARNINGS RELEASE ON FEBRUARY 27, 2024, AFTER THE CLOSE OF TRADING. A CONFERENCE CALL WITH A SIMULTANEOUS WEBCAST TO DISCUSS THE 2023 FOURTH QUARTER RESULTS WILL BE HELD ON WEDNESDAY, FEBRUARY 28 AT 10:00 A.M. PACIFIC TIME. THE DIAL-IN NUMBER FOR U.S. PARTICIPANTS IS 888-596-4144. FOR PARTICIPANTS OUTSIDE THE U.S., THE DIAL-IN NUMBER IS 646-968-2525. THE CONFERE.

SABRA HEALTH CARE REIT, INC. ANNOUNCES FOURTH QUARTER 2023 EARNINGS RELEASE DATE AND CONFERENCE CALL; DECLARES COMMON DIVIDEND

IRVINE, CALIF.--(BUSINESS WIRE)-- #2023DIVIDENDS--SABRA HEALTH CARE REIT, INC. (NASDAQ: SBRA) ANNOUNCED TODAY THE TAX TREATMENT FOR ITS 2023 DISTRIBUTIONS. THE FOLLOWING TABLE SUMMARIZES, FOR INCOME TAX PURPOSES, THE NATURE OF CASH DISTRIBUTIONS PAID: SABRA HEALTH CARE REIT, INC. COMMON STOCK (CUSIP # 78573L106) RECORD DATE PAYABLE DATE DISTRIBUTION PER SHARE  TOTAL ORDINARY DIVIDENDS  NON- QUALIFIED DIVIDENDS  QUALIFIED DIVIDENDS  NON- DIVIDEND DISTRIBUTIONS 02/13/2023 02/28/2023 $ 0.3000000  $ 0.1709313.

SABRA HEALTH CARE REIT, INC. ANNOUNCES TAX TREATMENT OF 2023 DISTRIBUTIONS

IRVINE, CALIF.--(BUSINESS WIRE)-- #CAO--SABRA HEALTH CARE REIT, INC. (SABRA) (NASDAQ: SBRA) TODAY ANNOUNCED THAT JESSICA FLORES HAS BEEN APPOINTED EXECUTIVE VICE PRESIDENT AND CHIEF ACCOUNTING OFFICER AND, IN SUCH CAPACITY, HAS BEEN DESIGNATED BY THE COMPANY'S BOARD OF DIRECTORS AS THE COMPANY'S PRINCIPAL ACCOUNTING OFFICER. MS. FLORES CURRENTLY SERVES AS SABRA'S SENIOR VICE PRESIDENT  FINANCE AND CONTROLLER, A POSITION SHE HAS HELD SINCE JANUARY 2022. MS. FLORES JOINED SABRA IN MARCH 2011 AND HELD.

SABRA HEALTH CARE REIT APPOINTS JESSICA FLORES AS CHIEF ACCOUNTING OFFICER

IRVINE, CALIF.--(BUSINESS WIRE)-- #STIFEL--SABRA HEALTH CARE REIT, INC. (NASDAQ: SBRA) ANNOUNCED TODAY THAT RICK MATROS, THE COMPANY'S CHAIR AND CHIEF EXECUTIVE OFFICER, MICHAEL COSTA, THE COMPANY'S CHIEF FINANCIAL OFFICER, TALYA NEVO-HACOHEN, THE COMPANY'S CHIEF INVESTMENT OFFICER, AND LUKAS HARTWICH, THE COMPANY'S SENIOR VICE PRESIDENT OF FINANCE, WILL PARTICIPATE VIRTUALLY IN STIFEL'S 2024 SENIORS HOUSING AND HEALTHCARE REAL ESTATE CONFERENCE ON JANUARY 9, 2024. ABOUT SABRA SABRA HEALTH CARE REIT, INC.

SABRA HEALTH CARE REIT, INC. TO PARTICIPATE IN THE STIFEL 2024 SENIORS HOUSING AND HEALTHCARE REAL ESTATE CONFERENCE

IRVINE, CALIF.--(BUSINESS WIRE)-- #3Q23--SABRA HEALTH CARE REIT, INC. (SABRA, THE COMPANY OR WE) (NASDAQ: SBRA) TODAY ANNOUNCED ITS RESULTS OF OPERATIONS FOR THE THIRD QUARTER OF 2023. THIRD QUARTER 2023 RESULTS AND RECENT EVENTS RESULTS PER DILUTED COMMON SHARE FOR THE THIRD QUARTER OF 2023 WERE AS FOLLOWS: NET LOSS: $(0.07) FFO: $0.33 NORMALIZED FFO: $0.33 AFFO: $0.35 NORMALIZED AFFO: $0.34 EBITDARM COVERAGE SUMMARY: SKILLED NURSING/TRANSITIONAL CARE: 1.68X (1.61X EXCLUDING PROVIDER RELIEF FUND.

SABRA REPORTS THIRD QUARTER 2023 RESULTS

IRVINE, CALIF.--(BUSINESS WIRE)-- #NAREIT--SABRA HEALTH CARE REIT, INC. (NASDAQ: SBRA) ANNOUNCED TODAY THAT RICK MATROS, THE COMPANY'S CHAIR AND CHIEF EXECUTIVE OFFICER, MICHAEL COSTA, THE COMPANY'S CHIEF FINANCIAL OFFICER, DARRIN SMITH, THE COMPANY'S EXECUTIVE VICE PRESIDENT OF INVESTMENTS, JESSICA FLORES, THE COMPANY'S SENIOR VICE PRESIDENT OF FINANCE AND CONTROLLER, AND LUKAS HARTWICH, THE COMPANY'S SENIOR VICE PRESIDENT OF FINANCE, WILL ATTEND NAREIT'S REITWORLD 2023 ANNUAL CONFERENCE NOVEMBER 14-15,.

SABRA HEALTH CARE REIT, INC. TO ATTEND NAREIT'S REITWORLD 2023 ANNUAL CONFERENCE

IRVINE, CALIF.--(BUSINESS WIRE)-- #Q32023--SABRA HEALTH CARE REIT, INC. (NASDAQ: SBRA) ANNOUNCED TODAY THAT IT WILL ISSUE ITS 2023 THIRD QUARTER EARNINGS RELEASE ON NOVEMBER 6, 2023, AFTER THE CLOSE OF TRADING. A CONFERENCE CALL WITH A SIMULTANEOUS WEBCAST TO DISCUSS THE 2023 THIRD QUARTER RESULTS WILL BE HELD ON TUESDAY, NOVEMBER 7 AT 10:00 A.M. PACIFIC TIME. THE DIAL-IN NUMBER FOR U.S. PARTICIPANTS IS 888-880-4448. FOR PARTICIPANTS OUTSIDE THE U.S., THE DIAL-IN NUMBER IS 646-960-0572. THE CONFERENCE ID.

Sabra Health Care

SBRA

Price

Returns

Dividends

Yield

Dividends

No items found.

Financials Overview

Financials Overview

Financial Reports

No items found.

Diversification by Property Type

Diversification by Country

Press Releases

Related News, Articles and Videos

Score

You might also be interested in

SBRA.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Returns

Dividends

Yield

Dividends

No items found.

Financials Overview

Financials Overview

Financial Reports

No items found.

Diversification by Property Type

Diversification by Country

Press Releases

Related News, Articles and Videos

Score

You might also be interested in

SBRA